Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amanda J.W. Branten"'
Publikováno v:
Branten, A J, du Buf-Vereijken, P W, Vervloet, M & Wetzels, J F 2007, ' Mycophenolate Mofetil in Idiopathic Membranous Nephropathy : A Clinical Trial With Comparison to a Historic Control Group Treated With Cyclophosphamide ', American Journal of Kidney Diseases, vol. 50, no. 2, pp. 248-256 . https://doi.org/10.1053/j.ajkd.2007.05.015
American Journal of Kidney Diseases, 50, 248-56
American Journal of Kidney Diseases, 50, 2, pp. 248-56
American Journal of Kidney Diseases, 50(2), 248-256. W.B. Saunders Ltd
American Journal of Kidney Diseases, 50, 248-56
American Journal of Kidney Diseases, 50, 2, pp. 248-56
American Journal of Kidney Diseases, 50(2), 248-256. W.B. Saunders Ltd
Item does not contain fulltext BACKGROUND: Cyclophosphamide can decrease proteinuria and improve renal function in patients with idiopathic membranous nephropathy, but has a high risk of side effects. We studied whether mycophenolate mofetil (MMF) co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55192ee23cd3bee3ed2be0ec71a247a0
https://doi.org/10.1053/j.ajkd.2007.05.015
https://doi.org/10.1053/j.ajkd.2007.05.015
Publikováno v:
Nephrology, Dialysis, Transplantation, 19, 5, pp. 1142-8
Nephrology, Dialysis, Transplantation, 19, 1142-8
Nephrology, Dialysis, Transplantation, 19, 1142-8
Item does not contain fulltext BACKGROUND: Patients with idiopathic membranous nephropathy (iMN) and renal insufficiency have a high risk for progression to end-stage renal disease (ESRD). In the short term, treatment with oral cyclophosphamide and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3943b7907d8b4acd209a18d06aa59a
https://doi.org/10.1093/ndt/gfh036
https://doi.org/10.1093/ndt/gfh036
Autor:
Amanda J.W. Branten, Jacob Van Den Born, Jan L.J. Jansen, Karel J.M. Assmann, Jack F.M. Wetzels, null with the technical assistance of Henry B.P.M. Dijkman
Publikováno v:
Kidney International, 59(2), 693-701. ELSEVIER SCIENCE INC
Kidney International. Supplement, 59, 2, pp. 693--701
Kidney International. Supplement, 59, 693--701
Kidney International. Supplement, 59, 2, pp. 693--701
Kidney International. Supplement, 59, 693--701
Contains fulltext : 185644.pdf (Publisher’s version ) (Closed access) BACKGROUND: Nephrotic syndrome in childhood is mainly due to minimal change nephropathy. In general, it is characterized by selective proteinuria, by steroid responsiveness, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4edaa63941a5e2dafccd8b4ef0bc85d5
https://hdl.handle.net/2066/185644
https://hdl.handle.net/2066/185644
Autor:
Jack F.M. Wetzels, Amanda J.W. Branten
Publikováno v:
Nephron. 81:329-333
Most filtered proteins are reabsorbed by the renal proximal tubule by a mechanism that involves binding to the brush border membrane and endocytosis. Under normal conditions the low-molecular-weight protein β2-microglobulin (β2M), which is used to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf12bbf59cc1488a4e78fd86ba4091f4
https://doi.org/10.1159/000045301
https://doi.org/10.1159/000045301
Publikováno v:
Kidney International. Supplement, 53, pp. 1559-1573
Kidney International. Supplement, 53, 1559-1573
Kidney International. Supplement, 53, 1559-1573
Antihypertensive treatment of patients with proteinuric renal diseases: Risks or benefits of calcium channel blockers? In patients with proteinuric renal diseases the rate of progression of renal insufficiency is determined by the level of blood pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ed0bf03fc3789d3fefd5f6ab06f896
Publikováno v:
Annals of Neurology, 43, 265-267
Annals of Neurology, 43, pp. 265-267
Annals of Neurology, 43, pp. 265-267
We describe a 50-year-old male patient with hyponatremia (serum sodium level, 128 mEq/L) discovered during routine follow-up for Henoch-Schönlein nephritis. The patient was known to have a generalized idiopathic epilepsy and was on 2,000 mg/day of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3789ecf5b0b45b67eced0a456306d1d8
https://doi.org/10.1002/ana.410430219
https://doi.org/10.1002/ana.410430219
Publikováno v:
American Journal of Kidney Diseases, 46, 6, pp. 1012-29
American Journal of Kidney Diseases, 46, 1012-29
American Journal of Kidney Diseases, 46, 1012-29
Item does not contain fulltext Idiopathic membranous nephropathy is a common cause of nephrotic syndrome. The treatment of patients with idiopathic membranous nephropathy is heavily debated. Based on literature data and our own experience, we propose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdfc198f006fd34b1cb1191310de151
https://hdl.handle.net/2066/47577
https://hdl.handle.net/2066/47577
Publikováno v:
Nephrology, Dialysis, Transplantation, 20, 4, pp. 707-11
Nephrology, Dialysis, Transplantation, 20, 707-11
Nephrology, Dialysis, Transplantation, 20, 707-11
Item does not contain fulltext BACKGROUND: In daily clinical practice creatinine clearance is used as marker of glomerular filtration rate (GFR). As a result of the tubular secretion process endogenous creatinine clearance (ECC) overestimates glomeru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb4219ee250313f7b7bd57a84ccbfc2
https://doi.org/10.1093/ndt/gfh719
https://doi.org/10.1093/ndt/gfh719
Autor:
Jack F.M. Wetzels, Frank H. Bosch, Geert W. Feith, Daan A. Hollander, Ina S. Klasen, Peggy W. G. du Buf-Vereijken, Amanda J.W. Branten
Publikováno v:
Journal of the American Society of Nephrology : JASN. 16(1)
An accurate prediction of the prognosis of patients with idiopathic membranous nephropathy (iMN) should allow restriction of immunosuppressive treatment to patients who are at highest risk for ESRD. On the basis of retrospective studies, it has previ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15910daa0438c02486161e775450b6be
https://pubmed.ncbi.nlm.nih.gov/15563570
https://pubmed.ncbi.nlm.nih.gov/15563570
Publikováno v:
Nephrology, Dialysis, Transplantation, 19, 2754-60
Nephrology, Dialysis, Transplantation, 19, 11, pp. 2754-60
Nephrology, Dialysis, Transplantation, 19, 11, pp. 2754-60
Contains fulltext : 57754.pdf (Publisher’s version ) (Closed access) BACKGROUND: Ferritin is a high molecular weight protein which reflects body iron stores, but may also rise in the case of an acute phase response. Recently, ferritin has been iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c8e05661b86c19e9a438004e750984b
http://hdl.handle.net/2066/57754
http://hdl.handle.net/2066/57754